ListarArtículos (Medicina) por materia "Ladademstat (ORY-1001)"
Mostrando ítems 1-1 de 1
-
Artículo
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
(American Society of Clinical Oncology, 2020)PURPOSE Iadademstat is a novel, highly potent, and selective inhibitor of LSD1 (KDM1A), with preclinical in vitro and ...